Warning letter
Brand Packaging Group, Inc.: warning letter of Mar 17, 2023
FDA warning letter 633651 · Division of Human and Animal Food Operations East I
Key facts
| Reference number | 633651 |
|---|---|
| Company | Brand Packaging Group, Inc. |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Mar 17, 2023 |
| Posted date | Jul 11, 2023 |
| Issuing office | Division of Human and Animal Food Operations East I |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.75(h)(1), 111.315(d), 111.75(a)(1)(i), 111.75(a)(1)(ii), 111.75(c), 111.77(a) |
| Inspection city | Farmingdale |
| Inspection ZIP | 11735 |
| Inspection start date | Mar 29, 2022 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: